Subject
Pharmacology,Immunology,Immunology and Allergy
Reference38 articles.
1. Economic costs of benign prostatic hyperplasia in the private sector;Saigal;J. Urol.,2005
2. Overactive bladder symptom score to evaluate efficacy of solifenacin for the treatment of overactive bladder symptoms;Liu;Chin. Med. J. (engl).,2014
3. Urodynamic investigation of cyclophosphamide-induced overactive bladder in conscious rats;Pan;Chin. Med. J. (engl).,2012
4. Bladder outlet obstruction: progression from inflammation to fibrosis;Metcalfe;BJU Int.,2010
5. The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative study;He;Int. J. Surg.,2020